Search the Appendices of Resolution CM/Res(2018)1
2416 found
| INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
|---|---|---|---|---|---|---|---|---|
| ANAGRELIDE | L01XX35 | IT | I | None | VALID | |||
| ARSENIC TRIOXIDE | L01XX27 | IT | I | VALID | ||||
| PEGASPARGASE | L01XX24 | IT | I | VALID | ||||
| MITOTANE | L01XX23 | IT | I | None | VALID | |||
| LONIDAMINE | L01XX07 | IT | I | None | 16-09-2003 | VALID | ||
| HYDROXYCARBAMIDE | L01XX05 | IT | I | VALID | ||||
| IVOSIDENIB | L01XM02 | IT | I | 14-11-2023 | EMEA/H/C/005936 | 04-05-2023 | VALID | |
| TABELECLEUCEL | L01XL09 | IT | I | 18-08-2023 | EMEA/H/C/004577 | 16-12-2022 | VALID | |
| IDECABTAGENE VICLEUCEL | L01XL07 | IT | I | EMEA/H/C/004662 | 18-08-2021 | VALID | ||
| CILTACABTAGENE AUTOLEUCEL | L01XL05 | IT | I | 18-11-2022 | EMEA/H/C/005095 | 25-05-2022 | VALID | |
| TISAGENLECLEUCEL | L01XL04 | IT | I | 05-01-2021 | VALID | |||
| AXICABTAGENE CILOLEUCEL | L01XL03 | IT | I | VALID | ||||
| TALAZOPARIB | L01XK04 | IT | I | VALID | ||||
| RUCAPARIB | L01XK03 | IT | I | 15-11-2018 | EMEA/H/C/004272 | 23-08-2018 | VALID | |
| NIRAPARIB | L01XK02 | IT | Not authorised | 04-05-2018 | VALID | |||
| OLAPARIB | L01XK01 | IT | I | VALID | ||||
| SONIDEGIB | L01XJ02 | IT | I | 06-01-2021 | EMEA/H/C/002839 | 14-08-2015 | VALID | |
| VISMODEGIB | L01XJ01 | IT | I | VALID | ||||
| PANOBINOSTAT | L01XH03 | IT | I | 05-01-2021 | EMEA/H/C/003725 | 28-08-2015 | VALID | |
| IXAZOMIB | L01XG03 | IT | POM | 18-08-2017 | EMEA/H/C/003844 | 21-11-2016 | VALID | |
| CARFILZOMIB | L01XG02 | IT | I | VALID | ||||
| BORTEZOMIB | L01XG01 | IT | I | 09-03-2020 | VALID | |||
| BEXAROTENE | L01XF03 | IT | I | 23-01-2019 | VALID | |||
| FEDRATINIB | L01XE57 | IT | I | 01-06-2021 | EMEA/H/C/005026 | 08-02-2021 | VALID | |
| PADELIPORFIN | L01XD07 | IT | I | 04-05-2018 | EMEA/H/C/004182 | 15-11-2017 | VALID | |
| AMINOLEVULINIC ACID | L01XD04 | IT | POM | 18-08-2017 | EMEA/H/C/000744 | 07-09-2007 | VALID | |
| METHYL AMINOLEVULINATE | L01XD03 | IT | I | None | VALID | |||
| CETUXIMAB | L01XC06 | IT | I | None | VALID | |||
| TRASTUZUMAB | L01XC03 | IT | I | 13-05-2024 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
| PROCARBAZINE | L01XB01 | IT | I | None | VALID | |||
| OXALIPLATIN | L01XA03 | IT | I | None | VALID | |||
| NIVOLUMAB AND RELATLIMAB | L01FY02 | IT | I | 18-11-2022 | EMEA/H/C/005481 | 15-09-2022 | VALID | |
| PERTUZUMAB AND TRASTUZUMAB | L01FY01 | IT | I | VALID | ||||
| ELRANATAMAB | L01FX32 | IT | I | 13-05-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
| ZOLBETUXIMAB | L01FX31 | IT | POM | 01-08-2025 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
| TALQUETAMAB | L01FX29 | IT | I | 14-11-2023 | EMEA/H/C/005864 | 21-08-2023 | VALID | |
| GLOFITAMAB | L01FX28 | IT | I | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
| LONCASTUXIMAB TESIRINE | L01FX22 | IT | I | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
| TREMELIMUMAB | L01FX20 | IT | I | 18-08-2023 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
| AMIVANTAMAB | L01FX18 | IT | I | 28-04-2022 | EMEA/H/C/005454 | 09-12-2021 | VALID | |
| SACITUZUMAB GOVITECAN | L01FX17 | IT | I | 28-04-2022 | EMEA/H/C/005182 | 22-11-2021 | VALID | |
| POLATUZUMAB VEDOTIN | L01FX14 | IT | I | 27-01-2022 | VALID | |||
| ENFORTUMAB VEDOTIN | L01FX13 | IT | I | 18-11-2022 | EMEA/H/C/005392 | 13-04-2022 | VALID | |
| TAFASITAMAB | L01FX12 | IT | I | 19-10-2021 | EMEA/H/C/005436 | 26-08-2021 | VALID | |
| OLARATUMAB | L01FX10 | IT | Not authorised | 27-01-2022 | VALID | |||
| MOGAMULIZUMAB | L01FX09 | IT | I | 15-07-2020 | VALID | |||
| ELOTUZUMAB | L01FX08 | IT | I | 27-01-2022 | EMEA/H/C/003967 | 11-05-2016 | VALID | |
| BLINATUMOMAB | L01FX07 | IT | I | 19-02-2019 | EMEA/H/C/003731 | 23-11-2015 | VALID | |
| DINUTUXIMAB BETA | L01FX06 | IT | I | 27-01-2022 | VALID | |||
| BRENTUXIMAB VEDOTIN | L01FX05 | IT | I | VALID |